Report Detail
Global (United States, European Union and China) Soliris Intravenous Market Research Report 2019-2025
- RnM3635984 |
- 30 July, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Soliris Intravenous, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS).
In the last several years, Asia-Pacific market of Soliris Intravenous developed rapidly.Japan is the largest consumption place. Market competition is not intense.The FDA will not approve biosimilar applications for Soliris Intravenous before 16 March 2019; there is an ongoing debate over the length of exclusivity periods.
In 2019, the market size of Soliris Intravenous is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Soliris Intravenous.
This report studies the global market size of Soliris Intravenous, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Soliris Intravenous sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Alexion
...
Market Segment by Product Type
Plasma Exchange
Plasma Infusion
Market Segment by Application
PNH
AHUS
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Soliris Intravenous status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Soliris Intravenous manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Soliris Intravenous are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Soliris Intravenous Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Plasma Exchange
- 1.3.3 Plasma Infusion
- 1.4 Market Segment by Application
- 1.4.1 Global Soliris Intravenous Market Share by Application (2019-2025)
- 1.4.2 PNH
- 1.4.3 AHUS
- 1.4.4 Other
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Soliris Intravenous Market Size
- 2.1.1 Global Soliris Intravenous Revenue 2014-2025
- 2.1.2 Global Soliris Intravenous Sales 2014-2025
- 2.2 Soliris Intravenous Growth Rate by Regions
- 2.2.1 Global Soliris Intravenous Sales by Regions 2014-2019
- 2.2.2 Global Soliris Intravenous Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Soliris Intravenous Sales by Manufacturers
- 3.1.1 Soliris Intravenous Sales by Manufacturers 2014-2019
- 3.1.2 Soliris Intravenous Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Soliris Intravenous Revenue by Manufacturers (2014-2019)
- 3.2.2 Soliris Intravenous Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Soliris Intravenous Market Concentration Ratio (CR5 and HHI)
- 3.3 Soliris Intravenous Price by Manufacturers
- 3.4 Key Manufacturers Soliris Intravenous Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Soliris Intravenous Market
- 3.6 Key Manufacturers Soliris Intravenous Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Plasma Exchange Sales and Revenue (2014-2019)
- 4.1.2 Plasma Infusion Sales and Revenue (2014-2019)
- 4.2 Global Soliris Intravenous Sales Market Share by Type
- 4.3 Global Soliris Intravenous Revenue Market Share by Type
- 4.4 Soliris Intravenous Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Soliris Intravenous Sales by Application
6 United States
- 6.1 United States Soliris Intravenous Breakdown Data by Company
- 6.2 United States Soliris Intravenous Breakdown Data by Type
- 6.3 United States Soliris Intravenous Breakdown Data by Application
7 European Union
- 7.1 European Union Soliris Intravenous Breakdown Data by Company
- 7.2 European Union Soliris Intravenous Breakdown Data by Type
- 7.3 European Union Soliris Intravenous Breakdown Data by Application
8 China
- 8.1 China Soliris Intravenous Breakdown Data by Company
- 8.2 China Soliris Intravenous Breakdown Data by Type
- 8.3 China Soliris Intravenous Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Soliris Intravenous Breakdown Data by Company
- 9.2 Rest of World Soliris Intravenous Breakdown Data by Type
- 9.3 Rest of World Soliris Intravenous Breakdown Data by Application
- 9.4 Rest of World Soliris Intravenous Breakdown Data by Countries
- 9.4.1 Rest of World Soliris Intravenous Sales by Countries
- 9.4.2 Rest of World Soliris Intravenous Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Alexion
- 10.1.1 Alexion Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Soliris Intravenous
- 10.1.4 Soliris Intravenous Product Introduction
- 10.1.5 Alexion Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Soliris Intravenous Sales Channels
- 11.2.2 Soliris Intravenous Distributors
- 11.3 Soliris Intravenous Customers
12 Market Forecast
- 12.1 Global Soliris Intravenous Sales and Revenue Forecast 2019-2025
- 12.2 Global Soliris Intravenous Sales Forecast by Type
- 12.3 Global Soliris Intravenous Sales Forecast by Application
- 12.4 Soliris Intravenous Forecast by Regions
- 12.4.1 Global Soliris Intravenous Sales Forecast by Regions 2019-2025
- 12.4.2 Global Soliris Intravenous Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Soliris Intravenous. Industry analysis & Market Report on Soliris Intravenous is a syndicated market report, published as Global (United States, European Union and China) Soliris Intravenous Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Soliris Intravenous market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
